Ajax-Loading

Novartis AG - Current Deferred Revenue

Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Current-Deferred-Revenue" stands at 0.127 Billion United States Dollars as of 12/31/2024.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 29.59 percent compared to the value the year prior.
The 1 year change in percent is 29.59.
The 3 year change in percent is 3.25.
The 5 year change in percent is 11.40.
The 10 year change in percent is -61.40.

The Serie's long term average value is 5.52 Billion United States Dollars. It's latest available value, on 12/31/2024, is 97.70 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2020, to it's latest available value, on 12/31/2024, is +126.79%.
The Serie's change in percent from it's maximum value, on 03/31/2019, to it's latest available value, on 12/31/2024, is -99.67%.

Current Deferred Revenue for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Current Deferred Revenue905,699,262,464.00
LogoJohnson & Johnson - Current Deferred Revenue486,508,953,600.00
LogoAbbVie Inc - Current Deferred Revenue399,570,305,024.00
LogoRoche Holding AG - Current Deferred Revenue317,433,206,677.55
LogoAstraZeneca PLC - Current Deferred Revenue280,205,508,085.11